Evidence map›Paper›PMID 42516213›Full record

ArticlePathology oncology research : POR2026

Association between the histopathologic measurement of tumor-visceral peritoneal distance and prognosis in T3 colon adenocarcinoma.

Özgecan Hamdemir, Semin Ayhan, Ömer Atmış, Ömer Acar

Abstract read
In one paragraph

Article in Pathology oncology research : POR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Özgecan HamdemirDepartment of Pathology, Kafkas University Faculty of Medicine, Kars, Türkiye.
Semin AyhanDepartment of Pathology, Manisa Celal Bayar University Faculty of Medicine, Manisa, Türkiye.
Ömer AtmışDepartment of Pathology, Manisa Celal Bayar University Faculty of Medicine, Manisa, Türkiye.
Ömer AcarClinical Oncology, Kızıltepe State Hospital, Mardin, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the relationship between microscopic tumor-visceral peritoneal distance (T-VPD) and histopathological markers of aggressiveness in pT3 colon adenocarcinoma and to assess its prognostic significance. Methods: A total of 329 resection specimens were retrospectively analyzed. T-VPD was defined as the shortest distance between the deepest invasive tumor front and the true serosal surface. Cut-off values of ≤0.01 cm, ≤0.05 cm, ≤0.1 cm, and ≤0.5 cm were evaluated. Associations with adverse histopathological features were examined using multivariable logistic regression. Overall survival (OS) and disease-free survival (DFS) were analyzed in 181 patients with available follow-up using Kaplan-Meier curves and Cox regression. Results: T-VPD ≤0.5 cm was independently associated with lymphovascular invasion, whereas T-VPD ≤0.05 cm correlated with poor differentiation and tumor deposits. In OS analysis, advanced age, nodal metastasis, lymphovascular invasion, and perineural invasion were adverse prognostic factors, while a strong peritumoral lymphocytic response was protective. Tumor deposits predicted worse DFS, and peritumoral lymphocytic response remained protective. T-VPD was not an independent predictor of survival. Conclusion: T-VPD reflects aggressive tumor behavior but lacks independent prognostic value. Combined with established adverse features, it may provide additional information for risk stratification in pT3 colon cancer.

Indexed as

AdenocarcinomaColonic NeoplasmsPeritoneumAdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansLymphatic MetastasisMaleMiddle AgedNeoplasm InvasivenessPrognosisRetrospective StudiesSurvival Ratecolonic neoplasmslymphatic metastasisneoplasm invasivenessperineural invasionsurvival analysis

Identifiers

PMID42516213
PMCPMC13402222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.